EA200802169A1 - Способы анализа гидроксикарбоната лантана - Google Patents

Способы анализа гидроксикарбоната лантана

Info

Publication number
EA200802169A1
EA200802169A1 EA200802169A EA200802169A EA200802169A1 EA 200802169 A1 EA200802169 A1 EA 200802169A1 EA 200802169 A EA200802169 A EA 200802169A EA 200802169 A EA200802169 A EA 200802169A EA 200802169 A1 EA200802169 A1 EA 200802169A1
Authority
EA
Eurasian Patent Office
Prior art keywords
analysis
lanthane
hydroxycarbonate
methods
impurity
Prior art date
Application number
EA200802169A
Other languages
English (en)
Inventor
Дональд Халленбек
Сайман Бэйтс
Original Assignee
Шир Интернэшнл Лайсенсинг Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шир Интернэшнл Лайсенсинг Б.В. filed Critical Шир Интернэшнл Лайсенсинг Б.В.
Publication of EA200802169A1 publication Critical patent/EA200802169A1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F17/00—Compounds of rare earth metals
    • C01F17/20—Compounds containing only rare earth metals as the metal element
    • C01F17/247—Carbonates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • G01N23/207—Diffractometry using detectors, e.g. using a probe in a central position and one or more displaceable detectors in circumferential positions
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Geology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

Настоящее изобретение относится к способу анализа для аналитического определения количества примеси в твердом образце. Предлагаемый способ основан на дифракции рентгеновских лучей, предпочтительно с применением усовершенствованного метода Ритвельда.
EA200802169A 2006-05-05 2007-02-01 Способы анализа гидроксикарбоната лантана EA200802169A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/418,666 US20070259052A1 (en) 2006-05-05 2006-05-05 Assay for lanthanum hydroxycarbonate
PCT/US2007/061461 WO2007130721A2 (en) 2006-05-05 2007-02-01 Assay for lanthanum hydroxycarbonate

Publications (1)

Publication Number Publication Date
EA200802169A1 true EA200802169A1 (ru) 2009-06-30

Family

ID=38661464

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200802169A EA200802169A1 (ru) 2006-05-05 2007-02-01 Способы анализа гидроксикарбоната лантана

Country Status (15)

Country Link
US (3) US20070259052A1 (ru)
JP (1) JP2009536356A (ru)
KR (1) KR20090016465A (ru)
CN (1) CN101484798A (ru)
AU (1) AU2007248374A1 (ru)
BR (1) BRPI0710343A2 (ru)
CA (1) CA2651344A1 (ru)
EA (1) EA200802169A1 (ru)
IL (1) IL195051A0 (ru)
MA (1) MA31601B1 (ru)
MX (1) MX2008014148A (ru)
NO (1) NO20085063L (ru)
SG (1) SG171656A1 (ru)
TW (1) TW200742849A (ru)
WO (1) WO2007130721A2 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20060134225A1 (en) * 2004-10-15 2006-06-22 Moerck Rudi E Phosphate binder with reduced pill burden
WO2010106557A2 (en) * 2009-03-20 2010-09-23 Panacea Biotec Limited Stable pharmaceutical formulations comprising anhydrous lanthanum carbonate and process for preparation thereof
ES2407993T3 (es) * 2009-05-15 2013-06-17 Natco Pharma Limited Procedimiento para la preparación de carbonato de lantano dihidrato
EP3848040A1 (en) * 2010-05-12 2021-07-14 Spectrum Pharmaceuticals, Inc. Lanthanum dioxycarbonate and use
US8263119B2 (en) 2010-12-01 2012-09-11 Shire Llc Capsule formulations containing lanthanum compounds
US8697132B2 (en) 2010-12-01 2014-04-15 Shire Llc Capsule and powder formulations containing lanthanum compounds
CA2833645C (en) * 2011-05-17 2019-09-17 Zach System S.P.A. Method of detecting polymorphs using synchrotron radiation
EP2793955B1 (en) 2011-12-21 2018-04-11 IsoTherapeutics Group, LLC Radioactive compositions and methods for their therapeutic use
CN104379739A (zh) 2012-06-05 2015-02-25 3M创新有限公司 镧基微生物浓集剂
CN102671684B (zh) * 2012-06-06 2013-10-30 福州大学 一种复合光催化剂及其制备方法和应用
CN103604820A (zh) * 2013-11-27 2014-02-26 南京钢铁股份有限公司 一种提高xrd实验精度的方法
JP5968401B2 (ja) * 2014-11-12 2016-08-10 三菱重工業株式会社 高温部材の温度推定方法、準安定正方相の含有量測定方法、劣化判定方法
CN110579499A (zh) * 2018-06-08 2019-12-17 北京华睿鼎信科技有限公司 一种碳酸镧或其制剂中碱式碳酸镧杂质的检定方法
CN110095489A (zh) * 2019-05-22 2019-08-06 北京悦康科创医药科技股份有限公司 一种碳酸镧咀嚼片中杂质碱式碳酸镧的定量测定方法
CN111620363A (zh) * 2020-06-13 2020-09-04 南京卡文迪许生物工程技术有限公司 一种四水合碳酸镧的制备方法及其产品
CN113019305B (zh) * 2021-03-03 2021-10-15 重庆三峡学院 多孔碱式碳酸镧磷酸盐吸附剂的制备及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246246A (en) 1977-12-10 1981-01-20 Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry Method for manufacture of hydrated borates
US4592082A (en) * 1984-08-10 1986-05-27 The United States Of America As Represented By The United States Department Of Energy Quantitative determination of mineral composition by powder X-ray diffraction
JPH06705B2 (ja) 1985-12-19 1994-01-05 旭化成工業株式会社 リン酸イオンの固定化剤
US5045289A (en) 1989-10-04 1991-09-03 Research Corporation Technologies, Inc. Formation of rare earth carbonates using supercritical carbon dioxide
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
JPH06171950A (ja) 1992-12-02 1994-06-21 Shin Etsu Chem Co Ltd ランタンマンガナイト粉末の製造方法
CA2128199C (en) * 1994-07-15 1997-02-04 Bernard Charles Sherman Stable solid pharmaceutical compositions containing enalapril maleate
US5435986A (en) * 1994-08-30 1995-07-25 Industrial Technology Research Institute Method for preparing high purity aluminum hydroxide
GB9506126D0 (en) * 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
US6281503B1 (en) * 1998-05-06 2001-08-28 Quanta Vision, Inc. Non-invasive composition analysis
US20010014352A1 (en) * 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
US6055293A (en) * 1998-06-30 2000-04-25 Seh America, Inc. Method for identifying desired features in a crystal
CN1122702C (zh) 1998-12-29 2003-10-01 中国石油化工集团公司 一种烃类催化裂化硫转移助剂及其使用方法
AUPQ109499A0 (en) 1999-06-21 1999-07-15 Adelaide Brighton Management Limited Sample presentation for x-ray diffraction
US6160016A (en) * 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder
GB0015745D0 (en) 2000-06-27 2000-08-16 Shire Holdings Ag Treatment of bone diseases
EP1321142A1 (en) 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
US7469036B2 (en) * 2002-04-19 2008-12-23 Los Alamos National Security, Llc Analysis of macromolecules, ligands and macromolecule-ligand complexes
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US6678347B1 (en) 2002-07-26 2004-01-13 Hypernex, Inc. Method and apparatus for quantitative phase analysis of textured polycrystalline materials
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
US7256049B2 (en) 2003-09-04 2007-08-14 Tandem Labs Devices and methods for separating phospholipids from biological samples
DE10346433B4 (de) 2003-10-07 2006-05-11 Bruker Axs Gmbh Analytisches Verfahren zum Bestimmen von kristallographischen Phasen einer Messprobe
BRPI0513603A (pt) * 2004-07-27 2008-05-13 Shire Pharmaceuticals Inc uso de hidroxicarbonato de lantánio e composição farmacêutica
US20060134225A1 (en) 2004-10-15 2006-06-22 Moerck Rudi E Phosphate binder with reduced pill burden

Also Published As

Publication number Publication date
US20100092576A1 (en) 2010-04-15
WO2007130721A3 (en) 2008-04-10
CA2651344A1 (en) 2007-11-15
AU2007248374A2 (en) 2008-11-27
SG171656A1 (en) 2011-06-29
NO20085063L (no) 2008-12-04
TW200742849A (en) 2007-11-16
US20080089948A1 (en) 2008-04-17
US20070259052A1 (en) 2007-11-08
CN101484798A (zh) 2009-07-15
MA31601B1 (fr) 2010-08-02
MX2008014148A (es) 2009-01-27
AU2007248374A1 (en) 2007-11-15
JP2009536356A (ja) 2009-10-08
US7618656B2 (en) 2009-11-17
IL195051A0 (en) 2009-08-03
KR20090016465A (ko) 2009-02-13
WO2007130721A2 (en) 2007-11-15
BRPI0710343A2 (pt) 2011-08-09

Similar Documents

Publication Publication Date Title
EA200802169A1 (ru) Способы анализа гидроксикарбоната лантана
IL205271A0 (en) Immunoassay analysis method
EP2454587A4 (en) DEVICES, METHODS, AND KITS FOR DETERMINING ANALYZ CONCENTRATIONS
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
EP4249605A3 (en) Methods for analyte detection
HK1206813A1 (en) Method for determining analyte concentration in a sample
EP2046971A4 (en) QUANTIFIED INTERNAL REFERENCE STANDARDS FOR IMMUNOHISTOCHEMISTRY AND USE
EP2106555A4 (en) PROCESS FOR S / TEM SAMPLE ANALYSIS
WO2010135574A3 (en) Systems and methods for determining the percentage of glycated hemoglobin
HK1140820A1 (en) A high sensivity multiparameter method for rare event analysis in a biological sample
HK1165001A1 (zh) 利用免疫法測定生物樣品中的雌馬酚的方法、用於該測定的試劑盒、以及判定受試者的雌馬酚產生能力的方法
EP1860437A4 (en) METHOD FOR EVALUATING SKIN CONDITION USING AS AN ANTIGEN ASSOCIATED WITH CARCINOMA OF SQUAMOUS CELLS
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
EP2279413A4 (en) PROCEDURE, ANTIBODIES AND KITS FOR DETECTING LIQUOR IN A SAMPLE
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
GB0904267D0 (en) Method for cell analysis
MX2009008525A (es) La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms.
WO2011074802A3 (ko) 전립선암 진단용 키트 및 진단방법
WO2012145516A3 (en) Methods and kits for quantitative determination of total organic acid content in a coolant
IL215322A0 (en) Method for detecting antibody against sith-1 in biological sample
WO2008115580A3 (en) Method for detecting nitrofuran
WO2012151039A3 (en) Compositions and methods for detecting mycobacterium
EP1916310A4 (en) METHOD FOR ANALYZING THE FUNCTION OF AN NKT CELL
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
MA35427B1 (fr) Immunoessai permettant de detecter des antibiotiques